Condition: Sarcopenia in Elderly · Sarcopenia · Sponsor: Animuscure Inc.
This clinical trial aims to find out whether AMC6156 can improve physical function and is safe in older adults with sarcopenia. Participants will take AMC6156 or a placebo daily for 12 weeks, and their movement, strength, and safety will be regularly monitored through tests and checkups.
This description comes directly from the study's public registry record.
Jooyeon Kim · +82-70-4105-6414 · yeoooonee@animuscure.com
Always discuss trial participation with your own doctor first.
| CHA Bundang Medical Center | Seongnam-si, Gyeonggi-do, South Korea | Recruiting |
| Seoul National University Bundang Hospital | Seongnam-si, Gyeonggi-do, South Korea | Not Yet Recruiting |
| Ajou University Hospital | Suwon, Gyeonggi-do, South Korea | Recruiting |
| Seoul National University Hospital | Seoul, Seoul, South Korea | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07072195